Treating an aggressive form of Non-Hodgkin lymphoma
Learn about the goals of treatment, the treatment options and the important questions to ask your healthcare team.
1 of 6
Slide 1
Non-Hodgkin’s lymphoma (NHL) is a type of cancer that begins in white blood cells called lymphocytes, which are part of the immune system. There are more than 60 different subtypes of NHL. These are categorized based on the type of lymphocytes in which the cancer cells develop, the appearance of the cancer cells, the genetic features of the cancer cells and other factors.
NHL is also categorized as indolent or aggressive. Indolent NHLs grow slowly, and may not be treated until symptoms appear. Aggressive NHLs spread quickly and will require fast and intense treatment.
Here, you will learn more about the goals for treating the aggressive types of this disease. You will also learn about available treatments, tests used to monitor your condition and questions to ask your doctor.
Sources: Cancer.net. “Lymphoma - Non-Hodgkin: Subtypes.” August 2019. Accessed October 9 + 28
- Cancer.net. “Lymphoma - Non-Hodgkin: Subtypes.” August 2019. Accessed October 9, 2020.
- Leukemia & Lymphoma Society. “NHL Subtypes.” 2020. Accessed October 9, 2020.
- Lymphoma Research Foundation. “About Lymphoma.” 2020. Accessed October 9, 2020.
- Lymphoma Research Foundation. “Getting the Facts: Mantle Cell Lymphoma.” July 2015. Accessed October 9, 2020.
- American Cancer Society. “Treating Non-Hodgkin Lymphoma.” 2020. Accessed October 9, 2020.
- Cancer.net. “Lymphoma - Non-Hodgkin: Symptoms and Signs.” August 2019. Accessed October 9, 2020.
- MedicineNet. “Mantle Cell Lymphoma.” 2020. Accessed October 9, 2020.
- American Cancer Society. “Chemotherapy for Non-Hodgkin Lymphoma.” August 1, 2018. Accessed October 9, 2020.
- National Cancer Institute. “Targeted Cancer Therapies.” September 30, 2020. Accessed October 9, 2020.
- Cancer Treatment Centers of America. “Non-Hodgkin lymphoma treatments.” 2020. Accessed October 9, 2020.
- American Cancer Society. “Targeted Therapy Drugs for Non-Hodgkin Lymphoma.” June 23, 2020. Accessed October 9, 2020.
- American Cancer Society. “Radiation Therapy for Non-Hodgkin Lymphoma.” August 26, 2019. Accessed October 9, 2020.
- Merck Manual Consumer Version. “Radiation Therapy for Cancer.” September 2020. Accessed October 9, 2020.
- American Cancer Society. “Immunotherapy for Non-Hodgkin Lymphoma.” August 3, 2020. Accessed October 9, 2020.
- Cancer.net. “Understanding Immunotherapy.” May 2020. Accessed October 9, 2020.
- MedicineNet. “More Aggressive Chemo May Help Younger Lymphoma Patients: Study.” November 24, 2011.
- NH Fowler. “Role of Maintenance Rituximab (Rituxan) Therapy In the Treatment of Follicular Lymphoma.” P & T: A Peer-Reviewed Journal for Formulary Management. September 2011. 36(9), 590–598.
- Cancer.net. “Understanding Maintenance Therapy.” May 2019. Accessed October 9, 2020.
- Cancer.net. “Bone Marrow/Stem Cell Transplantation.” 2020. Accessed October 9, 2020.
- American Cancer Society. “Types of Stem Cell and Bone Marrow Transplants.” March 2020. Accessed October 9, 2020.
- American Cancer Society. “Getting a Stem Cell or Bone Marrow Transplant.” March 2020. Accessed October 9, 2020.
- MedlinePlus. “Pelvic CT scan.” December 23, 2018. Accessed October 9, 2020.
- American Cancer Society. “CT Scan for Cancer.” November 30, 2015. Accessed October 9, 2020.
- National Cancer Institute. “PET scan.” 2020. Accessed October 9, 2020.
- American Cancer Society. “Nuclear Medicine Scans for Cancer.” August 29, 2019. Accessed October 9, 2020.
- Leukemia & Lymphoma Society. “Treatment for Aggressive NHL Subtypes.” 2020. Accessed October 9, 2020.
- National Cancer Institute. “Hematopoietic stem cell.” 2020. Accessed October 13, 2020.
- Johns Hopkins Medicine/The Sidney Kimmel Comprehensive Cancer Center. “Types of Bone Marrow Transplants.”
- Sarah C. Rutherford. “Surveillance Scanning in Lymphoma.” Clinical Advances in Hematology & Oncology. June 2019 - Volume 17, Issue 6.